288 related articles for article (PubMed ID: 12614156)
1. Structure of human pro-chymase: a model for the activating transition of granule-associated proteases.
Reiling KK; Krucinski J; Miercke LJ; Raymond WW; Caughey GH; Stroud RM
Biochemistry; 2003 Mar; 42(9):2616-24. PubMed ID: 12614156
[TBL] [Abstract][Full Text] [Related]
2. The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity.
Pereira PJ; Wang ZM; Rubin H; Huber R; Bode W; Schechter NM; Strobl S
J Mol Biol; 1999 Feb; 286(1):163-73. PubMed ID: 9931257
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of phenylmethanesulfonyl fluoride-treated human chymase at 1.9 A.
McGrath ME; Mirzadegan T; Schmidt BF
Biochemistry; 1997 Nov; 36(47):14318-24. PubMed ID: 9400368
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of an oligomer of proteolytic zymogens: detailed conformational analysis of the bovine ternary complex and implications for their activation.
Gomis-Rüth FX; Gómez-Ortiz M; Vendrell J; Ventura S; Bode W; Huber R; Avilés FX
J Mol Biol; 1997 Jun; 269(5):861-80. PubMed ID: 9223647
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the proenzyme domain of plasminogen.
Peisach E; Wang J; de los Santos T; Reich E; Ringe D
Biochemistry; 1999 Aug; 38(34):11180-8. PubMed ID: 10460175
[TBL] [Abstract][Full Text] [Related]
6. The 0.83 A resolution crystal structure of alpha-lytic protease reveals the detailed structure of the active site and identifies a source of conformational strain.
Fuhrmann CN; Kelch BA; Ota N; Agard DA
J Mol Biol; 2004 May; 338(5):999-1013. PubMed ID: 15111063
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the wild-type human procathepsin B at 2.5 A resolution reveals the native active site of a papain-like cysteine protease zymogen.
Podobnik M; Kuhelj R; Turk V; Turk D
J Mol Biol; 1997 Sep; 271(5):774-88. PubMed ID: 9299326
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes.
Khan AR; James MN
Protein Sci; 1998 Apr; 7(4):815-36. PubMed ID: 9568890
[TBL] [Abstract][Full Text] [Related]
9. Theoretical perspectives on the reaction mechanism of serine proteases: the reaction free energy profiles of the acylation process.
Ishida T; Kato S
J Am Chem Soc; 2003 Oct; 125(39):12035-48. PubMed ID: 14505425
[TBL] [Abstract][Full Text] [Related]
10. The three-dimensional structure of human procarboxypeptidase A2. Deciphering the basis of the inhibition, activation and intrinsic activity of the zymogen.
García-Sáez I; Reverter D; Vendrell J; Avilés FX; Coll M
EMBO J; 1997 Dec; 16(23):6906-13. PubMed ID: 9384570
[TBL] [Abstract][Full Text] [Related]
11. Substituted 3-(phenylsulfonyl)-1-phenylimidazolidine-2,4-dione derivatives as novel nonpeptide inhibitors of human heart chymase.
Niwata S; Fukami H; Sumida M; Ito A; Kakutani S; Saitoh M; Suzuki K; Imoto M; Shibata H; Imajo S; Kiso Y; Tanaka T; Nakazato H; Ishihara T; Takai S; Yamamoto D; Shiota N; Miyazaki M; Okunishi H; Kinoshita A; Urata H; Arakawa K
J Med Chem; 1997 Jul; 40(14):2156-63. PubMed ID: 9216834
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous inactivation of human tryptase involves conformational changes consistent with conversion of the active site to a zymogen-like structure.
Selwood T; McCaslin DR; Schechter NM
Biochemistry; 1998 Sep; 37(38):13174-83. PubMed ID: 9748324
[TBL] [Abstract][Full Text] [Related]
13. Human alpha-thrombin inhibition by the active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester: a comparative kinetic and X-ray crystallographic study.
Nardini M; Pesce A; Rizzi M; Casale E; Ferraccioli R; Balliano G; Milla P; Ascenzi P; Bolognesi M
J Mol Biol; 1996 May; 258(5):851-9. PubMed ID: 8637015
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of alpha-lytic protease by pro region C-terminal steric occlusion of the active site.
Sohl JL; Shiau AK; Rader SD; Wilk BJ; Agard DA
Biochemistry; 1997 Apr; 36(13):3894-902. PubMed ID: 9092819
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of an activation intermediate of cathepsin E.
Ostermann N; Gerhartz B; Worpenberg S; Trappe J; Eder J
J Mol Biol; 2004 Sep; 342(3):889-99. PubMed ID: 15342244
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the complex of human alpha-thrombin and nonhydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6.
Zdanov A; Wu S; DiMaio J; Konishi Y; Li Y; Wu X; Edwards BF; Martin PD; Cygler M
Proteins; 1993 Nov; 17(3):252-65. PubMed ID: 8272424
[TBL] [Abstract][Full Text] [Related]
17. Why does beta-secretase zymogen possess catalytic activity? Molecular modeling and molecular dynamics simulation studies.
Zuo Z; Gang C; Zou H; Mok PC; Zhu W; Chen K; Jiang H
Comput Biol Chem; 2007 Jun; 31(3):186-95. PubMed ID: 17500040
[TBL] [Abstract][Full Text] [Related]
18. Predicted solution structure of zymogen human coagulation FVII.
Perera L; Darden TA; Pedersen LG
J Comput Chem; 2002 Jan; 23(1):35-47. PubMed ID: 11913388
[TBL] [Abstract][Full Text] [Related]
19. Activation of the zymogen to urokinase-type plasminogen activator is associated with increased interdomain flexibility.
Behrens MA; Botkjaer KA; Goswami S; Oliveira CL; Jensen JK; Schar CR; Declerck PJ; Peterson CB; Andreasen PA; Pedersen JS
J Mol Biol; 2011 Aug; 411(2):417-29. PubMed ID: 21669207
[TBL] [Abstract][Full Text] [Related]
20. Structure of alpha-lytic protease complexed with its pro region.
Sauter NK; Mau T; Rader SD; Agard DA
Nat Struct Biol; 1998 Nov; 5(11):945-50. PubMed ID: 9808037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
